Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $735.20 +0.05%
Revenue Growth %: +21.1%
Financial Fact:
Total expenses: 857.32M
Today's EPS Names:
TAYD, PKE, More
Revenue Growth %: +21.1%
Financial Fact:
Total expenses: 857.32M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Reiterates Neutral Rating on Regeneron Pharma (REGN)
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
